Fibrate + Statin = Reduction of CV Risk?

A recently published study that has appeared in the BMJ has assessed whether fenofibrate, added to statin treatment, reduces persistent cardiovascular risk in adults with metabolic syndrome. Investigating nearly 30,000 people with metabolic syndrome (≥40 years)...

Lower LDL is not always necessarily better

Cholesterol: is lower always better? In light of recent trends in treatment approaches that essentially are set to drive LDL cholesterol to very low serum concentrations, the results of a study published in the prestigious journal Neurology are of interest. 96,043...

Preventative medicines still charted to the end of life

A retrospective cohort study conducted in the United Kingdom has examined preventative medication prescribing on hospital admission and discharge for patients with advanced lung cancer, and the factors affecting this prescribing. The study included patients from two...